Rhythm control in heart failure patients with atrial fibrillation: Contemporary challenges including the role of ablation

Journal of the American College of Cardiology

Volumn 64, Issue 7, 2014, Pages 710-721

  Trulock, Kevin M ^a   Narayan, Sanjiv M ^b   Piccini, Jonathan P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

antiarrhythmic drug therapy; atrial fibrillation; catheter ablation; heart failure; rhythm control

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BUCINDOLOL; DOFETILIDE; RANOLAZINE;

ARTICLE; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; DISEASE CONTROL; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART FAILURE; HEART PERFORMANCE; HEART RHYTHM; HEART TAMPONADE; HUMAN; PATHOPHYSIOLOGY; PHARMACEUTICAL CARE; POPULATION RISK; PRIORITY JOURNAL; PULMONARY VEIN OBSTRUCTION; QUALITY OF LIFE; RISK ASSESSMENT; SURGICAL APPROACH; TREATMENT OUTCOME;

ANTIARRHYTHMIC DRUG THERAPY; ATRIAL FIBRILLATION; CATHETER ABLATION; HEART FAILURE; RHYTHM CONTROL;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; ELECTROCARDIOGRAPHY; HEART FAILURE; HEART RATE; HUMANS; TREATMENT OUTCOME;

EID: 84905978936     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.06.1169     Document Type: Review

References (109)

1. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952 (Pubitemid 28446646)
2. P. Dorian, W. Jung, and D. Newman et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy J Am Coll Cardiol 36 2000 1303 1309
3. T.J. Wang, M.G. Larson, and D. Levy et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study Circulation 107 2003 2920 2925 (Pubitemid 36736633)
4. D. Roy, M. Talajic, and S. Nattel et al. Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677 (Pubitemid 351860859)
5. D.G. Wyse, A.L. Waldo, and J.P. DiMarco et al. A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833 (Pubitemid 35417773)
6. S. Saksena, A. Slee, and A.L. Waldo et al. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses J Am Coll Cardiol 58 2011 1975 1985
7. S.S. Chugh, R. Havmoeller, and K. Narayanan et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study Circulation 129 2014 837 847
8. I.H. Stevenson, H. Teichtahl, D. Cunnington, S. Ciavarella, I. Gordon, and J.M. Kalman Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function Eur Heart J 29 2008 1662 1669 (Pubitemid 351957544)
9. T.J. Wang, H. Parise, and D. Levy et al. Obesity and the risk of new-onset atrial fibrillation JAMA 292 2004 2471 2477 (Pubitemid 39552671)
10. J. Heeringa, D.A. van der Kuip, and A. Hofman et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study Eur Heart J 27 2006 949 953
11. D.M. Lloyd-Jones, T.J. Wang, and E.P. Leip et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 2004 1042 1046 (Pubitemid 39319000)
12. G.S. Bleumink, A.M. Knetsch, and M.C. Sturkenboom et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure: the Rotterdam Study Eur Heart J 25 2004 1614 1619 (Pubitemid 39209281)
13. K.K. Ho, J.L. Pinsky, W.B. Kannel, and D. Levy The epidemiology of heart failure: the Framingham Study J Am Coll Cardiol 22 1993 6A 13A (Pubitemid 23285789)
14. L.S. Jenkins, M. Brodsky, and E. Schron et al. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Am Heart J 149 2005 112 120
15. I. Suman-Horduna, D. Roy, and N. Frasure-Smith et al. Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure J Am Coll Cardiol 61 2013 455 460
16. E. Schron, E. Friedmann, and S.A. Thomas Does health-related quality of life predict hospitalization or mortality in patients with atrial fibrillation? J Cardiovasc Electrophysiol 25 2014 23 28
17. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
18. H.J. Lin, P.A. Wolf, and M. Kelly-Hayes et al. Stroke severity in atrial fibrillation. The Framingham Study Stroke 27 1996 1760 1764 (Pubitemid 26332500)
19. D.G. Sherman, S.G. Kim, and B.S. Boop et al. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study Arch Intern Med 165 2005 1185 1191 (Pubitemid 40723655)
20. T.J. Bunch, H.T. May, and T.L. Bair et al. Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score Heart Rhythm 10 2013 1272 1277
21. S. Themistoclakis, A. Corrado, and F.E. Marchlinski et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation J Am Coll Cardiol 55 2010 735 743
22. E.B. Saad, A. d'Avila, and I.P. Costa et al. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study Circ Arrhythm Electrophysiol 4 2011 615 621
23. A.A. Grace, and S.M. Narayan Common threads in atrial fibrillation and heart failure Heart Fail Clin 9 2013 373 383 vii
24. S.S. Chugh, J.L. Blackshear, W.K. Shen, S.C. Hammill, and B.J. Gersh Epidemiology and natural history of atrial fibrillation: clinical implications J Am Coll Cardiol 37 2001 371 378
25. D.L. Dries, D.V. Exner, B.J. Gersh, M.J. Domanski, M.A. Waclawiw, and L.W. Stevenson Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials J Am Coll Cardiol 32 1998 695 703 (Pubitemid 28435256)
26. G.V. Naccarelli, H. Varker, J. Lin, and K.L. Schulman Increasing prevalence of atrial fibrillation and flutter in the United States Am J Cardiol 104 2009 1534 1539
27. W.G. Stevenson, L.W. Stevenson, and H.R. Middlekauff et al. Improving survival for patients with atrial fibrillation and advanced heart failure J Am Coll Cardiol 28 1996 1458 1463 (Pubitemid 26391850)
28. P. Khazanie, L. Liang, and L.G. Qualls et al. Outcomes of Medicare beneficiaries with heart failure and atrial fibrillation J Am Coll Cardiol Heart Fail 2 2014 41 48
29. J. Kalifa, J. Jalife, and A.V. Zaitsev et al. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation Circulation 108 2003 668 671 (Pubitemid 36999249)
30. G.G. Lalani, A. Schricker, M. Gibson, A. Rostamian, D.E. Krummen, and S.M. Narayan Atrial conduction slows immediately before the onset of human atrial fibrillation: a bi-atrial contact mapping study of transitions to atrial fibrillation J Am Coll Cardiol 59 2012 595 606
31. R.W. Mills, S.M. Narayan, and A.D. McCulloch Mechanisms of conduction slowing during myocardial stretch by ventricular volume loading in the rabbit Am J Physiol Heart Circ Physiol 295 2008 H1270 H1278
32. M.K. Stiles, B. John, and C.X. Wong et al. Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the "second factor." J Am Coll Cardiol 53 2009 1182 1191
33. J.S. Healey, C.W. Israel, and S.J. Connolly et al. Relevance of electrical remodeling in human atrial fibrillation: results of the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial mechanisms of atrial fibrillation study Circ Arrhythm Electrophysiol 5 2012 626 631
34. D. Li, K. Shinagawa, and L. Pang et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure Circulation 104 2001 2608 2614 (Pubitemid 33104801)
35. V. Markides, R.J. Schilling, S.Y. Ho, A.W. Chow, D.W. Davies, and N.S. Peters Characterization of left atrial activation in the intact human heart Circulation 107 2003 733 739 (Pubitemid 36222602)
36. S.M. Narayan, M.R. Franz, P. Clopton, E.J. Pruvot, and D.E. Krummen Repolarization alternans reveals vulnerability to human atrial fibrillation Circulation 123 2011 2922 2930
37. P.C. Deedwania, and J.A. Lardizabal Atrial fibrillation in heart failure: a comprehensive review Am J Medicine 123 2010 198 204
38. D.M. Clark, V.J. Plumb, A.E. Epstein, and G.N. Kay Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation J Am Coll Cardiol 30 1997 1039 1045 (Pubitemid 27435898)
39. P. Nerheim, S. Birger-Botkin, L. Piracha, and B. Olshansky Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia Circulation 110 2004 247 252 (Pubitemid 38960795)
40. R.J. Raymond, A.J. Lee, F.C. Messineo, W.J. Manning, and D.I. Silverman Cardiac performance early after cardioversion from atrial fibrillation Am Heart J 136 1998 435 442 (Pubitemid 28413540)
41. R.J. Shelton, A.L. Clark, and K. Goode et al. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study) Heart 95 2009 924 930
42. V. Fuster, L.E. Ryden, and D.S. Cannom et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines J Am Coll Cardiol 57 2011 e101 e198
43. L.S. Wann, A.B. Curtis, and K.A. Ellenbogen et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines J Am Coll Cardiol 57 2011 1330 1337
44. S. Singla, P. Karam, A.J. Deshmukh, J. Mehta, and H. Paydak Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation J Cardiovasc Pharmacol Ther 17 2012 12 20
45. D. Roy, M. Talajic, P. Dorian Canadian Trial of Atrial Fibrillation Investigators Amiodarone to prevent recurrence of atrial fibrillation N Engl J Med 342 2000 913 920 (Pubitemid 30177051)
46. P. Kirchhof, G. Breithardt, and E. Aliot et al. Personalized management of atrial fibrillation: proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference Europace 15 2013 1540 1556
47. B.M. Scirica, D.A. Morrow, and H. Hod et al. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial Circulation 116 2007 1647 1652 (Pubitemid 47537839)
48. P.H. Stone Ranolazine: new paradigm for management of myocardial ischemia, myocardial dysfunction, and arrhythmias Cardiol Clin 26 2008 603 614
49. N. Fragakis, K.C. Koskinas, D.G. Katritsis, E.D. Pagourelias, T. Zografos, and P. Geleris Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation Am J Cardiol 110 2012 673 677
50. K.C. Koskinas, N. Fragakis, D. Katritsis, V. Skeberis, and V. Vassilikos Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation Europace 16 2014 973 979
51. P. Milberg, G. Frommeyer, and S. Ghezelbash et al. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness Europace 15 2013 761 769
52. M.D. Ezekowitz, R. Nagarakanti, and A. Lubinski et al. A randomized trial of budiodarone in paroxysmal atrial fibrillation J Interv Cardiac Electrophysiol 34 2012 1 9
53. 1389 Arg/Gly adrenergic receptor polymorphism J Am Coll Cardiol Heart Fail 1 2013 338 344
54. H. Calkins Catheter ablation to maintain sinus rhythm Circulation 125 2012 1439 1445
55. M.H. Kong, J.P. Piccini, and T.D. Bahnson Efficacy of adjunctive ablation of complex fractionated atrial electrograms and pulmonary vein isolation for the treatment of atrial fibrillation: a meta-analysis of randomized controlled trials Europace 13 2011 193 204
56. K. Shivkumar, K.A. Ellenbogen, J.D. Hummel, J.M. Miller, and J.S. Steinberg Acute termination of human atrial fibrillation by identification and catheter ablation of localized rotors and sources: first multicenter experience of focal impulse and rotor modulation (FIRM) ablation J Cardiovasc Electrophysiol 23 2012 1277 1285
57. S.M. Narayan, D.E. Krummen, K. Shivkumar, P. Clopton, W.J. Rappel, and J.M. Miller Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial J Am Coll Cardiol 60 2012 628 636
58. H. Calkins, K.H. Kuck, and R. Cappato et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design Europace 14 2012 528 606
59. D.J. Wilber, C. Pappone, and P. Neuzil et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial JAMA 303 2010 333 340
60. A. Noheria, A. Kumar, J.V. Wylie Jr., and M.E. Josephson Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review Arch Intern Med 168 2008 581 586 (Pubitemid 351468392)
61. T. Terasawa, E.M. Balk, and M. Chung et al. Systematic review: comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation Ann Intern Med 151 2009 191 202
62. J. Cosedis Nielsen, A. Johannessen, and P. Raatikainen et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation N Engl J Med 367 2012 1587 1595
63. O.M. Wazni, N.F. Marrouche, and D.O. Martin et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial JAMA 293 2005 2634 2640 (Pubitemid 40744248)
64. C.A. Morillo, A. Verma, and S.J. Connolly et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial JAMA 311 2014 692 700
65. M.S. Chen, N.F. Marrouche, and Y. Khaykin et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function J Am Coll Cardiol 43 2004 1004 1009 (Pubitemid 38352980)
66. P.J. Gentlesk, W.H. Sauer, and E.P. Gerstenfeld et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation J Cardiovasc Electrophysiol 18 2007 9 14 (Pubitemid 44952735)
67. M.A. Wood, C. Brown-Mahoney, G.N. Kay, and K.A. Ellenbogen Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis Circulation 101 2000 1138 1144 (Pubitemid 30146615)
68. M.N. Khan, P. Jais, and J. Cummings et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure N Engl J Med 359 2008 1778 1785
69. M.R. MacDonald, D.T. Connelly, and N.M. Hawkins et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial Heart 97 2011 740 747
70. R.J. Hunter, T.J. Berriman, and I. Diab et al. A randomised controlled trial of Catheter Ablation versus Medical Treatment of Atrial Fibrillation in Heart Failure (the CAMTAF trial) Circ Arrhythm Electrophysiol 7 2014 31 38
71. D.G. Jones, S.K. Haldar, and W. Hussain et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure J Am Coll Cardiol 61 2013 1894 1903
72. T. Machino-Ohtsuka, Y. Seo, and T. Ishizu et al. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction J Am Coll Cardiol 62 2013 1857 1865
73. S.B. Wilton, A. Fundytus, and W.A. Ghali et al. Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction Am J Cardiol 106 2010 1284 1291
74. M. Faustino, C. Pizzi, and D. Capuzzi et al. The impact of atrial fibrillation termination mode during catheter ablation procedure on maintenance of sinus rhythm Heart Rhythm 2014 May 24 [E-pub ahead of print]
75. Y.M. Park, J.I. Choi, H.E. Lim, S.W. Park, and Y.H. Kim Is pursuit of termination of atrial fibrillation during catheter ablation of great value in patients with longstanding persistent atrial fibrillation? J Cardiovasc Electrophysiol 23 2012 1051 1058
76. M.D. O'Neill, M. Wright, and S. Knecht et al. Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint Eur Heart J 30 2009 1105 1112
77. C.S. Elayi, L. Di Biase, and C. Barrett et al. Atrial fibrillation termination as a procedural endpoint during ablation in long-standing persistent atrial fibrillation Heart Rhythm 7 2010 1216 1223
78. F. Gaita, D. Caponi, and M. Scaglione et al. Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation Circ Arrhythm Electrophysiol 1 2008 269 275
79. E. Anter, C.M. Tschabrunn, F.M. Contreras-Valdes, A.E. Buxton, and M.E. Josephson Radiofrequency ablation annotation algorithm reduces the incidence of linear gaps and reconnection after pulmonary vein isolation Heart Rhythm 11 2014 783 790
80. A. Metzner, B. Reissmann, and P. Rausch et al. One-year clinical outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon Circ Arrhythm Electrophysiol 7 2014 288 292
81. M. Kimura, S. Sasaki, and S. Owada et al. Comparison of lesion formation between contact force-guided and non-guided circumferential pulmonary vein isolation: a prospective, randomized study Heart Rhythm 11 2014 984 991
82. T. Baykaner, P. Clopton, and G.G. Lalani et al. Targeted ablation at stable atrial fibrillation sources improves success over conventional ablation in high-risk patients: a substudy of the CONFIRM trial Can J Cardiol 29 2013 1218 1226
83. B. Gersak, A. Pernat, B. Robic, and M. Sinkovec Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation J Cardiovasc Electrophysiol 23 2012 1059 1066
84. B. Gersak, M.O. Zembala, and D. Muller et al. European experience of the convergent atrial fibrillation procedure: multicenter outcomes in consecutive patients J Thorac Cardiovasc Surg 147 2014 1411 1416
85. A.K. Gehi, J.P. Mounsey, and I. Pursell et al. Hybrid epicardial-endocardial ablation using a pericardioscopic technique for the treatment of atrial fibrillation Heart Rhythm 10 2013 22 28
86. M.H. Kong, R.D. Lopes, J.P. Piccini, V. Hasselblad, T.D. Bahnson, and S.M. Al-Khatib Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized controlled trials Cardiovasc Ther 28 2010 311 326
87. S.M. Al-Khatib, N.M. Allen LaPointe, and R. Chatterjee et al. Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review Ann Intern Med 160 2014 760 773
88. J.R. Doty, D.B. Doty, and K.W. Jones et al. Comparison of standard Maze III and radiofrequency Maze operations for treatment of atrial fibrillation J Thorac Cardiovasc Surg 133 2007 1037 1044 (Pubitemid 46435915)
89. J.M. Stulak, J.A. Dearani, and T.M. Sundt 3rd et al. Superiority of cut-and-sew technique for the Cox maze procedure: comparison with radiofrequency ablation J Thorac Cardiovasc Surg 133 2007 1022 1027 (Pubitemid 46435920)
90. N. Ad, L. Henry, and S. Hunt The impact of surgical ablation in patients with low ejection fraction, heart failure, and atrial fibrillation Eur J Cardiothorac Surg 40 2011 70 76
91. A.S. Gami, D.O. Hodge, and R.M. Herges et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation J Am Coll Cardiol 49 2007 565 571 (Pubitemid 46177437)
92. A.M. Chamberlain, S.K. Agarwal, M. Ambrose, A.R. Folsom, E.Z. Soliman, and A. Alonso Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) study Am Heart J 159 2010 850 856
93. R.R. Huxley, A. Alonso, and F.L. Lopez et al. Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study Heart 98 2012 133 138
94. A. Alonso, F.L. Lopez, and K. Matsushita et al. Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study Circulation 123 2011 2946 2953
95. A.W. Haider, M.G. Larson, S.S. Franklin, D. Levy Framingham Heart Study Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study Ann Intern Med 138 2003 10 16 (Pubitemid 36232089)
96. D.M. Gopal, A.P. Kalogeropoulos, and V.V. Georgiopoulou et al. Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study Am Heart J 164 2012 236 242
97. T. Fall, S. Hagg, and R. Magi et al. The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis PLoS Med 10 2013 e1001474
98. A. Pazin-Filho, A. Kottgen, and A.G. Bertoni et al. HbA1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study Diabetologia 51 2008 2197 2204
99. A. Kottgen, S.D. Russell, and L.R. Loehr et al. Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study J Am Soc Nephrol 18 2007 1307 1315 (Pubitemid 46536917)
100. D.J. Gottlieb, G. Yenokyan, and A.B. Newman et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the Sleep Heart Health Study Circulation 122 2010 352 360
101. D. Levy, M.G. Larson, R.S. Vasan, W.B. Kannel, and K.K. Ho The progression from hypertension to congestive heart failure JAMA 275 1996 1557 1562 (Pubitemid 26154241)
102. G.H. Bardy, K.L. Lee, and D.B. Mark et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237 (Pubitemid 40110811)
103. A. Kadish, A. Dyer, and J.P. Daubert et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158 (Pubitemid 38637995)
104. J.J. McMurray, J. Ostergren, and K. Swedberg et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Lancet 362 2003 767 771 (Pubitemid 37093916)
105. B.M. Massie, P.E. Carson, and J.J. McMurray et al. Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
106. A.L. Taylor, S. Ziesche, and C. Yancy et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
107. F. Zannad, J.J. McMurray, and H. Krum et al. Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
108. L. Kober, C. Torp-Pedersen, and J.J. McMurray et al. Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687 (Pubitemid 351860860)
109. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1987 1429 1435